These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 11694457
1. Retinoic acid protects against hyperoxia-mediated cell-cycle arrest of lung alveolar epithelial cells by preserving late G1 cyclin activities. Nabeyrat E, Corroyer S, Besnard V, Cazals-Laville V, Bourbon J, Clement A. Am J Respir Cell Mol Biol; 2001 Oct; 25(4):507-14. PubMed ID: 11694457 [Abstract] [Full Text] [Related]
2. Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to p21(CIP1) downregulation. Nabeyrat E, Corroyer S, Epaud R, Besnard V, Cazals V, Clement A. Am J Physiol Lung Cell Mol Physiol; 2000 Jan; 278(1):L42-50. PubMed ID: 10645889 [Abstract] [Full Text] [Related]
3. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids. Corroyer S, Nabeyrat E, Clement A. Endocrinology; 1997 Sep; 138(9):3677-85. PubMed ID: 9275052 [Abstract] [Full Text] [Related]
4. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells. Gong J, Ammanamanchi S, Ko TC, Brattain MG. Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668 [Abstract] [Full Text] [Related]
7. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 15; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
8. CDK2 is a target for retinoic acid-mediated growth inhibition in MCF-7 human breast cancer cells. Teixeira C, Pratt MA. Mol Endocrinol; 1997 Aug 15; 11(9):1191-202. PubMed ID: 9259311 [Abstract] [Full Text] [Related]
9. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells. Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y. J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049 [Abstract] [Full Text] [Related]
10. A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest. Casini T, Pelicci PG. Oncogene; 1999 May 27; 18(21):3235-43. PubMed ID: 10359529 [Abstract] [Full Text] [Related]
13. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells. Taipale M, Tiihonen E, Heiskanen A, Laiho M. Exp Cell Res; 2000 Aug 25; 259(1):107-16. PubMed ID: 10942583 [Abstract] [Full Text] [Related]
14. Mechanisms of cell cycle arrest in response to TGF-beta in progestin-dependent and -independent growth of mammary tumors. Salatino M, Labriola L, Schillaci R, Charreau EH, Elizalde PV. Exp Cell Res; 2001 Apr 15; 265(1):152-66. PubMed ID: 11281653 [Abstract] [Full Text] [Related]
15. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation. Malashicheva AB, Kislyakova TV, Aksenov ND, Osipov KA, Pospelov VA. Oncogene; 2000 Aug 10; 19(34):3858-65. PubMed ID: 10951579 [Abstract] [Full Text] [Related]
18. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS. Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577 [Abstract] [Full Text] [Related]
19. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S, Lowe M, Herliczek TW, Keyomarsi K. Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471 [Abstract] [Full Text] [Related]
20. TGF-beta 1 induces the cyclin-dependent kinase inhibitor p27Kip1 mRNA and protein in murine B cells. Kamesaki H, Nishizawa K, Michaud GY, Cossman J, Kiyono T. J Immunol; 1998 Jan 15; 160(2):770-7. PubMed ID: 9551912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]